Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

79 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Integrative clustering reveals a novel split in the luminal A subtype of breast cancer with impact on outcome.
Aure MR, Vitelli V, Jernström S, Kumar S, Krohn M, Due EU, Haukaas TH, Leivonen SK, Vollan HK, Lüders T, Rødland E, Vaske CJ, Zhao W, Møller EK, Nord S, Giskeødegård GF, Bathen TF, Caldas C, Tramm T, Alsner J, Overgaard J, Geisler J, Bukholm IR, Naume B, Schlichting E, Sauer T, Mills GB, Kåresen R, Mælandsmo GM, Lingjærde OC, Frigessi A, Kristensen VN, Børresen-Dale AL, Sahlberg KK; OSBREAC. Aure MR, et al. Among authors: frigessi a. Breast Cancer Res. 2017 Mar 29;19(1):44. doi: 10.1186/s13058-017-0812-y. Breast Cancer Res. 2017. PMID: 28356166 Free PMC article.
Genome-wide DNA methylation profiles in progression to in situ and invasive carcinoma of the breast with impact on gene transcription and prognosis.
Fleischer T, Frigessi A, Johnson KC, Edvardsen H, Touleimat N, Klajic J, Riis ML, Haakensen VD, Wärnberg F, Naume B, Helland A, Børresen-Dale AL, Tost J, Christensen BC, Kristensen VN. Fleischer T, et al. Among authors: frigessi a. Genome Biol. 2014;15(8):435. doi: 10.1186/PREACCEPT-2333349012841587. Epub 2014 Aug 22. Genome Biol. 2014. PMID: 25146004 Free PMC article.
Combining gene signatures improves prediction of breast cancer survival.
Zhao X, Rødland EA, Sørlie T, Naume B, Langerød A, Frigessi A, Kristensen VN, Børresen-Dale AL, Lingjærde OC. Zhao X, et al. Among authors: frigessi a. PLoS One. 2011 Mar 10;6(3):e17845. doi: 10.1371/journal.pone.0017845. PLoS One. 2011. PMID: 21423775 Free PMC article.
Principles and methods of integrative genomic analyses in cancer.
Kristensen VN, Lingjærde OC, Russnes HG, Vollan HK, Frigessi A, Børresen-Dale AL. Kristensen VN, et al. Among authors: frigessi a. Nat Rev Cancer. 2014 May;14(5):299-313. doi: 10.1038/nrc3721. Nat Rev Cancer. 2014. PMID: 24759209 Review.
An independent poor-prognosis subtype of breast cancer defined by a distinct tumor immune microenvironment.
Tekpli X, Lien T, Røssevold AH, Nebdal D, Borgen E, Ohnstad HO, Kyte JA, Vallon-Christersson J, Fongaard M, Due EU, Svartdal LG, Sveli MAT, Garred Ø; OSBREAC; Frigessi A, Sahlberg KK, Sørlie T, Russnes HG, Naume B, Kristensen VN. Tekpli X, et al. Among authors: frigessi a. Nat Commun. 2019 Dec 3;10(1):5499. doi: 10.1038/s41467-019-13329-5. Nat Commun. 2019. PMID: 31796750 Free PMC article.
Toward Personalized Computer Simulation of Breast Cancer Treatment: A Multiscale Pharmacokinetic and Pharmacodynamic Model Informed by Multitype Patient Data.
Lai X, Geier OM, Fleischer T, Garred Ø, Borgen E, Funke SW, Kumar S, Rognes ME, Seierstad T, Børresen-Dale AL, Kristensen VN, Engebraaten O, Köhn-Luque A, Frigessi A. Lai X, et al. Among authors: frigessi a. Cancer Res. 2019 Aug 15;79(16):4293-4304. doi: 10.1158/0008-5472.CAN-18-1804. Epub 2019 May 22. Cancer Res. 2019. PMID: 31118201 Clinical Trial.
79 results